Research Article
Prognostic Significance of mTOR and PTEN in Patients with Esophageal Squamous Cell Carcinoma
Table 1
Baseline characteristics of the study patients and their tumors, according to mTOR expression.
| Characteristics | Total | mTOR-high | mTOR-low | value | | | |
| Gender | | | | 0.686 | Male | 114 | 71 | 43 | | Female | 34 | 23 | 11 | | Age | | | | 0.473 | <65 | 51 | 30 | 21 | | 65 | 97 | 64 | 33 | | Tumor length | | | | 0.302 | <5 | 64 | 44 | 20 | | 5 | 84 | 50 | 34 | | pT status | | | | <0.001 | pT1 | 21 | 6 | 15 | | pT2 | 37 | 11 | 26 | | pT3 | 76 | 64 | 12 | | pT4 | 14 | 13 | 1 | | pN status | | | | <0.001 | pN0 | 56 | 19 | 37 | | PN1 | 92 | 75 | 17 | | TNM stage (AJCC) | | | | <0.001 | I | 20 | 6 | 14 | | II | 46 | 16 | 30 | | III | 82 | 72 | 10 | | Differentiation grade | | | | 0.007 | Well | 20 | 13 | 7 | | Moderate | 81 | 43 | 38 | | Poor | 47 | 38 | 9 | |
|
|
AJCC: American Joint Commission on Cancer Staging; pT: pathological tumor stage; pN: pathological node stage.
|